Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Dec 06,2016
Biomarker Predicts Fatal Leukemia Development in Previously Treated Cancer Patients
    Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).  While risk factors for the development of t-MNs are currently not well understood, a newRead more
More
Dec 06,2016
Parkinson Disease Linked to Microbiome
    Only a few decades ago, it would have been largely inconceivable that resident microbes of our digestive tract would play a significant role in neurological diseases. Though roughly 75% of patients with Parkinson's disease (PD) have gastrointestinal (GI) abnormalities, primarily constipation, it had been assumed for many years that this was a side effect ofRead more
More
Parkinson Disease Linked to Microbiome
Dec 05,2016
Engineered Flu Virus a Replicative Dud, but Stays Live
    Developing a live vaccine is a tricky balancing act. But it can become more of a sure thing if the vaccine developer puts a thumb on the scales. That's one way to describe the approach taken by Peking University researchers. They decided to tweak the influenza A virus genetically so that it would not onlyRead more
More
Dec 05,2016
Survey of Approved Drugs Intended to Shed Light on Potential New Therapies
    Researchers have created a map of all 1578 licensed drugs and their mechanisms of action as a means of identifying "uncharted waters” in the search for future treatments. Their analysis of drugs licensed through the U.S. FDA reveals that 667 separate proteins in the human body have had drugs developed against them—just an estimated 3.5%Read more
More
Survey of Approved Drugs Intended to Shed Light on Potential New Therapies
Dec 05,2016
Bioequivalence Study and Data Submission in FDA Abbreviated New Drug Application (ANDA)
Bioequivalence research is a key link in the development and application of generic drugs. As the pioneer and advocate of bioequivalence research, the U.S. Food and Drug Administration (FDA) has in-depth views on it. Starting with the history of equivalence and generic drugs, it introduces the FDA's methodological considerations, experimental design, evaluation standards, and dataRead more
More
Dec 02,2016
White Wine May Increase Risk of Skin Cancer
    "A bottle of white, a bottle of red, perhaps a bottle of rose instead,” Billy Joel croons in his famous song "Scenes from an Italian Restaurant.” However, you may want to skip that bottle of white according to a new study from researchers at Brown University's Warren Alpert Medical School. The findings from the newRead more
More
White Wine May Increase Risk of Skin Cancer
Dec 02,2016
Modified PEG Drug Delivery Method Evades Immune System Attack
    Duke University biomedical engineers have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.         Polyethylene glycol (PEG) is a polymer commonly found in commercial products from toothpaste to cosmetics as well as in pharmaceuticals. PEG is used as a thickener, solvent, softener, and moisture-carrier, but it canRead more
More
Dec 02,2016
Scientists Synthesize New Drug Against Chemotherapy-resistant Cancer
The scientists synthesized a new series of compounds called Aminoisothiazole and evaluated their anticancer effects using sea urchin embryos and human cancer cells. One of the molecules was shown to be potent and selectable.
More
Scientists Synthesize New Drug Against Chemotherapy-resistant Cancer
Dec 01,2016
A CRISPR Platform That Is More Efficient and Controllable
    A collaborative team of researchers from the Wellcome Trust Sanger Institute and the University of Cambridge has just described their recent work on generating a new CRISPR (clustered regularly interspaced short palindromic repeats) genome-editing platform that is freely available and works as a single-step system within every cell of the body and at every stageRead more
More
Dec 01,2016
Novel Technique May Lead to Design of New and Improved Antibiotics
    North Carolina State University scientists say they have discovered a way to make pinpoint changes to an enzyme-driven “assembly line” that will enable researchers to improve or change the properties of existing antibiotics as well as create designer compounds. Their work is the first to efficiently manipulate which building blocks the enzyme selects in theRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->